Renalytix Plc
RNLXY
$0.2051
-$0.0199-8.84%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 33.16% | 8.64% | 8.74% | 16.44% | 8.56% |
| Total Depreciation and Amortization | 250.00% | -157.97% | -36.11% | -14.96% | 258.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.53% | -2.84% | 342.13% | -75.81% | 562.62% |
| Change in Net Operating Assets | 96.96% | -485.69% | 6,216.67% | 99.15% | -151.25% |
| Cash from Operations | 50.98% | -60.96% | 38.60% | 16.68% | -10.09% |
| Capital Expenditure | -- | 66.67% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 66.67% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 43.40% | -1,392.68% |
| Issuance of Common Stock | -99.73% | 66.82% | 5,353.76% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 35.32% | -- | 100.00% | 98.46% |
| Cash from Financing | -99.70% | 93.13% | 895.46% | 52.39% | -986.73% |
| Foreign Exchange rate Adjustments | 200.00% | 116.87% | -153.90% | 169.37% | -167.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15,612.50% | 97.38% | 88.94% | 23.34% | -29.31% |
